CARDIOLYNX AG has a total of 40 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PFLEGER R CHEM FAB, WUHAN UNITED PHARMACEUTICAL CO LTD and SYNAPTEC DEV LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | China | 3 | |
#6 | United States | 3 | |
#7 | Argentina | 2 | |
#8 | Brazil | 2 | |
#9 | Israel | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | Singapore | 2 | |
#13 | Taiwan | 2 | |
#14 | South Africa | 2 | |
#15 | Hong Kong | 1 | |
#16 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Scherhag Armin | 31 |
#2 | Sartor Dirk | 30 |
#3 | Vankan Pierre | 13 |
#4 | Stuckler Hubert | 6 |
#5 | Armin Scherhag | 5 |
#6 | Dirk Sartor | 5 |
#7 | Stückler Hubert | 4 |
#8 | Stueckler Hubert | 2 |
#9 | Pierre Vankan | 2 |
#10 | Stckler Hubert | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016135262A1 | No donors for the treatment of impaired tissue perfusion | |
SG11201501014YA | Extended release compositions of an aminoalkyl nitrate | |
TW201204355A | Nitrate derivatives of pioglitazone | |
CN103080095A | Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases | |
EP2377855A1 | A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases | |
BRPI0923300A2 | "cilostazol nitrate derivatives for the treatment of vascular and metabolic diseases" |